This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schiefermeier, M. Articles by Sterz, F. Search for Related Content PubMed PubMed Citation Articles by Schiefermeier, M. Articles by Sterz, F. Pubmed/NCBI databases Medline Plus Health Information CPR Traumatic Brain Injury Related Collections Acute Cerebral Infarction Genetics of Stroke Lipid and lipoprotein metabolism

(Stroke. 2000;31:2068.)
© 2000 American Heart Association, Inc.

Original Contributions

Apolipoprotein E Polymorphism

Survival and Neurological Outcome After Cardiopulmonary Resuscitation

M. Schiefermeier, PhD; H. Kollegger, MD; C. Madl, MD; C. Schwarz, MSc; M. Holzer, MD; J. Kofler, MD F. Sterz, MD

From the Departments of Clinical Neurology (M.S., H.K., C.S.), Internal Medicine IV, Division of Intensive Care Medicine (C.M.), and Emergency Medicine (M.H., J.K., F.S.), University of Vienna, Vienna, Austria.

Correspondence to Mark Schiefermeier, PhD, Department of Clinical Neurology, University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. E-mail mark.schiefermeier{at}univie.ac.at

Background and Purpose—The apolipoprotein E 3/3 (apoE 3/3) genotype is associated with a reduced risk of developing Alzheimer’s disease and with a favorable neurological outcome after traumatic head injury. In vitro studies suggest that the most common genotype, apoE 3/3, may be involved in neuroprotective and neuroregenerative mechanisms. The aim of this study was to determine whether the apoE 3/3 genotype has an impact on survival and neurological outcome after cardiopulmonary resuscitation.

Methods—Eighty patients with cardiac arrest were investigated prospectively for their apoE genotype. Epidemiological data were assessed according to recommended guidelines. Patients were divided into 2 groups, ie, with the apoE 3/3 genotype present or absent, and tested for differences in survival and neurological outcome. Further statistical analysis with respect to survival and neurological outcome was performed by using a stepwise logistic regression analysis.

Results—Patients with the apoE 3/3 genotype had a significantly higher survival rate (64% versus 33%, P=0.007) and more often a favorable neurological outcome (55% versus 27%, P=0.013) compared with patients with other apoE genotypes. The apoE 3/3 genotype was shown to be a substantial predictive factor for a favorable neurological outcome (odds ratio 3.2) and was, apart from other essential factors, predictive for survival (odds ratio 4.4) after cardiopulmonary resuscitation.

Conclusions—These data give evidence that patients with the apoE 3/3 genotype have a better chance of recovery after cardiopulmonary resuscitation than do patients with apoE genotypes other than 3/3.

Key Words: apolipoproteins E • heart arrest • polymorphism • resuscitation • stroke outcome

This article has been cited by other articles:

				I. Zeltser, G. P. Jarvik, J. Bernbaum, G. Wernovsky, A. S. Nord, M. Gerdes, E. Zackai, R. Clancy, S. C. Nicolson, T. L. Spray, et al. Genetic factors are important determinants of neurodevelopmental outcome after repair of tetralogy of Fallot J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 91 - 97. [Abstract] [Full Text] [PDF]

				C Smith, D I Graham, L S Murray, J Stewart, and J A R Nicoll Association of APOE e4 and cerebrovascular pathology in traumatic brain injury. J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 363 - 366. [Abstract] [Full Text] [PDF]

				J. W. Gaynor, M. Gerdes, E. H. Zackai, J. Bernbaum, G. Wernovsky, R. R. Clancy, M. F. Newman, A. M. Saunders, P. J. Heagerty, J. A. D'Agostino, et al. Apolipoprotein E genotype and neurodevelopmental sequelae of infant cardiac surgery J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1736 - 1745. [Abstract] [Full Text] [PDF]

				W T Longstreth Jr, G D Schellenberg, C E Fahrenbruch, L A Cobb, M K Copass, and D S Siscovick Apolipoprotein E genotypes and outcome from out of hospital cardiac arrest J. Neurol. Neurosurg. Psychiatry, October 1, 2003; 74(10): 1441 - 1443. [Abstract] [Full Text] [PDF]

				A. Kay, A. Petzold, M. Kerr, G. Keir, E. Thompson, and J. Nicoll Decreased Cerebrospinal Fluid Apolipoprotein E After Subarachnoid Hemorrhage: Correlation With Injury Severity and Clinical Outcome Stroke, March 1, 2003; 34(3): 637 - 642. [Abstract] [Full Text] [PDF]

				B. W. McColl, D. I. Graham, C. J. Weir, F. White, and K. Horsburgh Endocytic Pathway Alterations in Human Hippocampus after Global Ischemia and the Influence of APOE Genotype Am. J. Pathol., January 1, 2003; 162(1): 273 - 281. [Abstract] [Full Text] [PDF]

				R. A. Short, N. R. Graff-Radford, J. Adamson, M. Baker, and M. Hutton Differences in Tau and Apolipoprotein E Polymorphism Frequencies in Sporadic Frontotemporal Lobar Degeneration Syndromes Arch Neurol, April 1, 2002; 59(4): 611 - 615. [Abstract] [Full Text] [PDF]

				J. Chapman, A. D. Korczyn, D. M. Karussis, and D. M. Michaelson The effects of APOE genotype on age at onset and progression of neurodegenerative diseases Neurology, October 23, 2001; 57(8): 1482 - 1485. [Abstract] [Full Text] [PDF]